Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) to Issue Dividend Increase – $0.48 Per Share

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Stockholders of record on Friday, March 21st will be given a dividend of 0.48 per share on Thursday, May 1st. The ex-dividend date is Friday, March 21st. This is a 2.1% increase from Hikma Pharmaceuticals’s previous dividend of $0.47.

Hikma Pharmaceuticals Price Performance

Shares of OTCMKTS HKMPF opened at $26.20 on Wednesday. Hikma Pharmaceuticals has a twelve month low of $22.33 and a twelve month high of $28.92. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.98 and a current ratio of 1.66. The company has a 50 day moving average of $26.71 and a 200 day moving average of $25.45.

Analyst Ratings Changes

Separately, Royal Bank of Canada raised Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a report on Tuesday, December 10th.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.